Lysophosphatidylcholine Acyltransferase 1 Deficiency Promotes Pulmonary Emphysema via Apoptosis of Alveolar Epithelial Cells
- 26 March 2022
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 45 (4) , 1765-1779
Abstract
Chronic obstructive pulmonary disease (COPD) is primarily caused by inhalation of cigarette smoke and is the third leading cause of death worldwide. Pulmonary surfactant, a complex of phospholipids and proteins, plays an essential role in respiration by reducing the surface tension in the alveoli. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is an enzyme that catalyzes the biosynthesis of surfactant lipids and is expressed in type 2 alveolar epithelial cells. Its dysfunction is suggested to be involved in various lung diseases; however, the relationship between LPCAT1 and COPD remains unclear. To investigate the role of LPCAT1 in the pathology of COPD, we analyzed an elastase-induced emphysema model using Lpcat1 knockout (KO) mice. In Lpcat1 KO mice, elastase-induced emphysema was significantly exacerbated with increased apoptotic cells, which was not ameliorated by supplementation with dipalmitoylphosphatidylcholine, which is a major component of the surfactant synthesized by LPCAT1. We subsequently evaluated the effects of cigarette smoking on primary human type 2 alveolar epithelial cells (hAEC2s) and found that cigarette smoke extract (CSE) downregulated the expression of Lpcat1. Furthermore, RNA sequencing analysis revealed that the apoptosis pathway was significantly enriched in CSE-treated primary hAEC2s. Finally, we downregulated the expression of Lpcat1 using small interfering RNA, which resulted in enhanced CSE-induced apoptosis in A549 cells. Taken together, cigarette smoke–induced downregulation of LPCAT1 can promote the exacerbation of pulmonary emphysema by increasing the susceptibility of alveolar epithelial cells to apoptosis, thereby suggesting that Lpcat1 is a novel therapeutic target for irreversible emphysema.Keywords
This publication has 53 references indexed in Scilit:
- Type 2 alveolar cells are stem cells in adult lungJournal of Clinical Investigation, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- What can in vitro models of COPD tell us?Pulmonary Pharmacology & Therapeutics, 2011
- Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary diseaseBMC Pulmonary Medicine, 2010
- Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 miceProceedings of the National Academy of Sciences, 2010
- LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in miceJournal of Clinical Investigation, 2010
- Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancerJournal of Molecular Medicine, 2008
- Animal models of chronic obstructive pulmonary diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cellsProceedings of the National Academy of Sciences, 2006
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959